Free Trial

INSPECS Group (SPEC) Competitors

GBX 72
-2.00 (-2.70%)
(As of 03:34 PM ET)

SPEC vs. BVC, TSTL, POLB, CEL, EAH, REDX, DXRX, AGL, ETX, and VLG

Should you be buying INSPECS Group stock or one of its competitors? The main competitors of INSPECS Group include BATM Advanced Communications (BVC), Tristel (TSTL), Poolbeg Pharma (POLB), Celadon Pharmaceuticals (CEL), ECO Animal Health Group (EAH), Redx Pharma (REDX), Diaceutics (DXRX), ANGLE (AGL), e-therapeutics (ETX), and Venture Life Group (VLG). These companies are all part of the "medical" sector.

INSPECS Group vs.

INSPECS Group (LON:SPEC) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, community ranking, analyst recommendations, earnings and media sentiment.

INSPECS Group pays an annual dividend of GBX 1 per share and has a dividend yield of 1.4%. BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 5.7%. INSPECS Group pays out -10,000.0% of its earnings in the form of a dividend.

In the previous week, BATM Advanced Communications had 1 more articles in the media than INSPECS Group. MarketBeat recorded 1 mentions for BATM Advanced Communications and 0 mentions for INSPECS Group. BATM Advanced Communications' average media sentiment score of 0.58 beat INSPECS Group's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the news media.

Company Overall Sentiment
INSPECS Group Neutral
BATM Advanced Communications Positive

BATM Advanced Communications has a net margin of -0.16% compared to INSPECS Group's net margin of -0.49%. BATM Advanced Communications' return on equity of -0.17% beat INSPECS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
INSPECS Group-0.49% -0.94% 0.79%
BATM Advanced Communications -0.16%-0.17%0.25%

BATM Advanced Communications has lower revenue, but higher earnings than INSPECS Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INSPECS Group£203.29M0.35-£1.19M-£0.01-6,950.00
BATM Advanced Communications£122.83M0.63£2.51MN/AN/A

INSPECS Group has a beta of 2.16, suggesting that its share price is 116% more volatile than the S&P 500. Comparatively, BATM Advanced Communications has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

67.0% of INSPECS Group shares are held by institutional investors. Comparatively, 41.8% of BATM Advanced Communications shares are held by institutional investors. 25.6% of INSPECS Group shares are held by insiders. Comparatively, 26.2% of BATM Advanced Communications shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

BATM Advanced Communications received 185 more outperform votes than INSPECS Group when rated by MarketBeat users. However, 100.00% of users gave INSPECS Group an outperform vote while only 49.48% of users gave BATM Advanced Communications an outperform vote.

CompanyUnderperformOutperform
INSPECS GroupOutperform Votes
5
100.00%
Underperform Votes
No Votes
BATM Advanced CommunicationsOutperform Votes
190
49.48%
Underperform Votes
194
50.52%

Summary

BATM Advanced Communications beats INSPECS Group on 10 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPEC vs. The Competition

MetricINSPECS GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£70.66M£4.52B£5.03B£1.43B
Dividend Yield2.00%1.82%44.82%11.84%
P/E Ratio-6,950.00321.62180.111,705.37
Price / Sales0.35168.292,398.72302,801.70
Price / Cash1.6398.7032.5932.84
Price / Book0.683.785.022.72
Net Income-£1.19M£143.69M£103.06M£165.27M
7 Day Performance-1.70%0.28%0.99%4.01%
1 Month Performance32.38%1.56%5.71%5.66%
1 Year Performance-43.03%-1.85%7.40%11.50%

INSPECS Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
0 of 5 stars
GBX 19
-0.3%
N/A-28.9%£82.88M£122.83M2,800.00980Gap Down
TSTL
Tristel
0.3962 of 5 stars
GBX 450
-0.6%
GBX 390
-13.3%
+31.3%£213.84M£39.49M3,750.00208
POLB
Poolbeg Pharma
0 of 5 stars
GBX 13.55
flat
N/A+68.5%£67.75MN/A-1,355.0012
CEL
Celadon Pharmaceuticals
0 of 5 stars
GBX 105
+2.4%
GBX 222.50
+111.9%
-38.1%£67.42M£11,258.00-807.6924Gap Down
EAH
ECO Animal Health Group
0 of 5 stars
GBX 118
flat
N/A+3.6%£79.93M£88.46M-5,900.00234
REDX
Redx Pharma
0 of 5 stars
GBX 15
+31.6%
N/A-53.1%£58.35M£4.20M-150.00101News Coverage
Gap Up
High Trading Volume
DXRX
Diaceutics
1.0708 of 5 stars
GBX 102.50
+4.6%
GBX 150
+46.3%
+40.8%£86.80M£21.90M10,500.00151Analyst Forecast
News Coverage
High Trading Volume
AGL
ANGLE
1.6719 of 5 stars
GBX 21.25
+1.2%
GBX 70
+229.4%
+4.9%£55.37M£1.82M-236.11173Gap Down
ETX
e-therapeutics
0 of 5 stars
GBX 9
-6.7%
N/A-27.3%£52.59M£295,000.00-450.0034Positive News
High Trading Volume
VLG
Venture Life Group
0 of 5 stars
GBX 40.50
flat
N/A-0.7%£51.23M£48.57M4,050.00153

Related Companies and Tools

This page (LON:SPEC) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners